Site Map

Main Pages of the Site

Home Page, English

Home Page, French

 

The Company

The Company: A Clearly Focused Business | Targeting Markets with “Block-Buster” Potential | With a Strong Development Pipeline | Offering Competitive Advantages

Organization: Dr. Frank Bobe, President and Chief Executive Officer | Dr. Henry Khouri, Vice-President, Clinical Development

Mission and Vision: Mission | Vision

Company History: Financing History | Milestones

 

Investor Relations

Corporate Governance: BioAxone Corporate Governance Team  | Board of Directors | Spinal Cord Injury Clinical Advisory Board | Ophthalmology Clinical Advisory Board | Scientific Advisory Board

Business Opportunities: Business Opportunities

 

Products

Products: Spinal Cord Injury (SCI) | Age related Macular Degeneration (AMD) | Glaucoma | Cancer

Science: Scientific platform

Product Pipelines: BA-210 | Cethrin® | BA-1049

Intellectual Property: Intellectual Property Status

 

Clinical

Clinical Development

Clinical Trials

Patient Resources

Clinical Sites Login

 

About Us

News

Contact Us

External Email Login

 
© BioAxone Thérapeutique Inc. 2005